Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3621
Peer-review started: July 4, 2020
First decision: July 24, 2020
Revised: July 29, 2020
Accepted: August 26, 2020
Article in press: August 26, 2020
Published online: September 6, 2020
Processing time: 61 Days and 20.8 Hours
Core tip: The immune system plays a central role in coronavirus disease 2019 (COVID-19), being responsible for clinical manifestations and prognosis. Hyper-activation of the immune response against severe acute respiratory syndrome coronavirus 2 may result, in some cases, in development of unwanted autoimmune disorders. COVID-19 has been associated with immune-mediated systemic or organ-selective manifestations, some of which fulfill the diagnostic or classification criteria of specific autoimmune diseases. Though it is still unknown whether these medical conditions represent transitory post-infectious epiphenomena, the use of therapeutic agents targeting the immune system may perhaps prevent their chronicization which leads to development of autoimmune diseases.
